Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02037035 · ClinicalTrials.gov registry record · Early Phase 1
Examining The Effect Of Ketamine On Glutamate/Glutamine Cycling
A Early Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 36
- Enrollment target
NCT02037035 is a Early Phase 1 study that has completed, run by Yale University. The registered enrollment target is 36 participants.
The verdict
NCT02037035, a Early Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 36 participants
- Enrollment target
Study Summary
This study is looking at the mechanisms underlying the behavioral effects of ketamine in healthy and depressed individuals.
Interventions
- DRUG Ketamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2013-07 |
| Est. Completion | 2021-06 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02037035
The ClinicalTrials.gov registry entry for NCT02037035 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ketamine is the first listed.
NCT02037035 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02037035 about?
NCT02037035 is a clinical study titled "Examining The Effect Of Ketamine On Glutamate/Glutamine Cycling". This study is looking at the mechanisms underlying the behavioral effects of ketamine in healthy and depressed individuals.
What is the current status of trial NCT02037035?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 36 participants. The study started on 2013-07. Estimated completion is 2021-06.
What interventions are being tested in trial NCT02037035?
The interventions under investigation include: Ketamine (DRUG).
Who is sponsoring clinical trial NCT02037035?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.